This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did ...

House Republicans introduced a proposal seeking to cut Medicaid spending by hundreds of billions of dollars. Healthcare ...

The nation’s independent cardiology practices are facing serious challenges, such as financial pressures, rising competition and fragmented technology. These struggles have left many practices ...

The Midwest Health Purchasers Collaborative (MHPC), a nonprofit employer purchasing organization, has teamed up with Vida Health, a virtual obesity and metabolic health provider, to offer ...

A new TV show, The Pitt, is winning rave reviews from healthcare workers for accurately depicting the crisis facing emergency rooms. With a packed waiting room of desperate people, the limited ...

A Bristol Myers Squibb immunotherapy currently approved as a first-line treatment for metastatic melanoma has failed a pivotal clinical trial intended to support expanding the therapy’s use to ...

The obesity rate has stopped increasing in the U.S., due in part to the growing use of GLP-1s — with one in eight Americans having taken one last year. While it’s certainly good news that the ...

When the 2025 Medicare Advantage Star Ratings were announced, only 42% of plans with prescription drug coverage scored four or five stars, down from 68% in 2022. This marks the third consecutive ...

Despite opposition from Democrats, Robert F. Kennedy Jr. was confirmed as Health and Human Services secretary by the Senate on Thursday. RFK Jr. has drawn some criticism over his skepticism of ...

Oral Genome is revolutionizing preventive healthcare with its highly sensitive and specific saliva-based, periodontal caries (tooth decay), and diabetes screening test, delivering results that ...

Receiving a diagnosis for a chronic illness or a life-altering, life-limiting condition can feel like having the wind knocked out of you. Unfortunately, many of us have been there. As a patient ...

The obesity drugs currently available address a broad swath of patients who struggle to manage their weight. While Aardvark Therapeutics is interested in serving this market, first it wants to ...